Clinical trial · Interventional
Use of v Care in Abdominal Hysterectomy
NCT02371811CI-TRIAL-00028860completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators use v care during abdominal hysterectomy and evaluate its effect on duration of operation time, surgical complications and vaginal length.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Uterine Fibroid | Uterine Corpus Leiomyoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| uterine manipulator (v care) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- v care group
- description
- In this group we will use (v care) uterine manipulator during abdominal hysterectomy.
- interventionNames
- Device: uterine manipulator (v care)
- type
- NO_INTERVENTION
- label
- control group
- description
- In this group we will do abdominal hysterectomy without v care.
Primary outcomes (1)
- measure
- Vaginal length
- timeFrame
- within 1 week postoperative
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * benign causes for hysterectomy Exclusion Criteria: * malignant causes for hysterectomy
References
Publications (0)
Data not yet available
No reference posted for this study.